|Signatures of mutational processes in human cancer|
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
|Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis|
C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ...
Journal of the National Cancer Institute 98 (4), 262-272, 2006
|The landscape of cancer genes and mutational processes in breast cancer|
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
|Landscape of somatic mutations in 560 breast cancer whole-genome sequences|
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
|Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series|
C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ...
Clinical cancer research 13 (11), 3207-3214, 2007
|Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures|
P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ...
Breast Cancer Research 10 (4), R65, 2008
|Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade|
S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ...
Journal of clinical oncology 25 (10), 1239, 2007
|Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial|
S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ...
Annals of oncology 25 (8), 1544-1550, 2014
|Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes|
C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ...
Clinical cancer research 14 (16), 5158-5165, 2008
|Subclonal diversification of primary breast cancer revealed by multiregion sequencing|
LR Yates, M Gerstung, S Knappskog, C Desmedt, G Gundem, P Van Loo, ...
Nature medicine 21 (7), 751, 2015
|CD4+ follicular helper T cell infiltration predicts breast cancer survival|
C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ...
The Journal of clinical investigation 123 (7), 2873-2892, 2013
|Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen|
S Loi, B Haibe-Kains, C Desmedt, P Wirapati, F Lallemand, AM Tutt, ...
BMC genomics 9 (1), 239, 2008
|Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer|
Y Li, L Zou, Q Li, B Haibe-Kains, R Tian, Y Li, C Desmedt, C Sotiriou, ...
Nature medicine 16 (2), 214-218, 2010
|A three-gene model to robustly identify breast cancer molecular subtypes|
B Haibe-Kains, C Desmedt, S Loi, AC Culhane, G Bontempi, ...
Journal of the National Cancer Institute 104 (4), 311-325, 2012
|Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes|
JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ...
Science 345 (6196), 2014
|Genomic evolution of breast cancer metastasis and relapse|
LR Yates, S Knappskog, D Wedge, JHR Farmery, S Gonzalez, ...
Cancer cell 32 (2), 169-184. e7, 2017
|Genomic index of sensitivity to endocrine therapy for breast cancer|
WF Symmans, C Hatzis, C Sotiriou, F Andre, F Peintinger, P Regitnig, ...
Journal of clinical oncology 28 (27), 4111, 2010
|Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer|
F Rothe, M Ignatiadis, C Chaboteaux, B Haibe-Kains, N Kheddoumi, ...
PloS one 6 (6), e20980, 2011
|Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis|
M Ignatiadis, SK Singhal, C Desmedt, B Haibe-Kains, C Criscitiello, ...
Journal of clinical oncology 30 (16), 1996-2004, 2012
|Genomic grade index is associated with response to chemotherapy in patients with breast cancer|
C Liedtke, C Hatzis, WF Symmans, C Desmedt, B Haibe-Kains, V Valero, ...
Journal of clinical oncology 27 (19), 3185, 2009